On May 14, 2014, Transgenomic Inc (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, announced the appointment of John D. Thompson to its Board of Directors. His appointment was effective May 14, 2014.Transgenomic Inc (NASDAQ:TBIO), net profit margin is -61.50% and weekly performance is -9.64%. On last trading day company shares ended up $3.75. Analysts mean target price for the company is $13.00. Transgenomic Inc (NASDAQ:TBIO), distance from 50-day simple moving average (SMA50) is -16.58%.
Sify Technologies Limited (ADR) (NASDAQ:SIFY)’s stock gained 2.32% to $2.24. The company on Apr. 22 announced its consolidated results under International Financial Reporting Standards (IFRS) for the fiscal year 2013-14. Sify Technologies Limited (ADR) (NASDAQ:SIFY), fell 5.93% in last trading session and ended the day on $2.06. SIFY, Gross Margin is 45.90% and its return on assets is 7.60%. Sify Technologies Limited (ADR) (NASDAQ:SIFY), quarterly performance is 1.48%.
Two other finalists LightPath Technologies, Inc. (NASDAQ:LPTH), and NaviSite (NAVI), offer variations on hosted and cloud services, respectively, zeroing in on some more specific enterprise requirements in their effort to differentiate their offers in a crowded service provider field. LightPath Technologies, Inc. (NASDAQ:LPTH), shares moved down 5.92% in last trading session and was closed at $1.43, while trading in range of $1.43 – 1.52. LightPath Technologies, Inc. (NASDAQ:LPTH), year to date (YTD) performance is 5.15%.
Trina Solar Limited (ADR) (NYSE:TSL), has reported the net revenues as $444.8 million in the Q1 of the FY2014, which has witnessed a YoY increase of 70.9% and a decrease of 15.4% on a quarterly basis. Trina Solar Limited (ADR) (NYSE:TSL), ended the last trading day at $12.83. Company weekly volatility is calculated as 8.02% and price to cash ratio as 1.88. Trina Solar Limited (ADR) (NYSE:TSL), showed a positive weekly performance of 21.04%.
CDW Corp (NASDAQ:CDW), announced the pricing of a public offering of 15,000,000 shares of its common stock held by selling stockholders at a price to the public of $28.35 per share. The underwriter has a 30-day option to purchase up to an additional 2,250,000 shares of common stock from the selling stockholders at the public offering price, less underwriting discounts. CDW Corporation will not receive any of the proceeds from the sale of the shares of common stock. The offering is expected to close on May 28, 2014. CDW Corp (NASDAQ:CDW), net profit margin is 1.40% and weekly performance is -5.26%. On last trading day company shares ended up $28.11. Analysts mean target price for the company is $32.00. CDW Corp (NASDAQ:CDW), distance from 50-day simple moving average (SMA50) is 1.37%.